FDA Approves Second Generation of Simplot GMO Spuds

— Written By
en Español / em Português
Español

El inglés es el idioma de control de esta página. En la medida en que haya algún conflicto entre la traducción al inglés y la traducción, el inglés prevalece.

Al hacer clic en el enlace de traducción se activa un servicio de traducción gratuito para convertir la página al español. Al igual que con cualquier traducción por Internet, la conversión no es sensible al contexto y puede que no traduzca el texto en su significado original. NC State Extension no garantiza la exactitud del texto traducido. Por favor, tenga en cuenta que algunas aplicaciones y/o servicios pueden no funcionar como se espera cuando se traducen.


Português

Inglês é o idioma de controle desta página. Na medida que haja algum conflito entre o texto original em Inglês e a tradução, o Inglês prevalece.

Ao clicar no link de tradução, um serviço gratuito de tradução será ativado para converter a página para o Português. Como em qualquer tradução pela internet, a conversão não é sensivel ao contexto e pode não ocorrer a tradução para o significado orginal. O serviço de Extensão da Carolina do Norte (NC State Extension) não garante a exatidão do texto traduzido. Por favor, observe que algumas funções ou serviços podem não funcionar como esperado após a tradução.


English

English is the controlling language of this page. To the extent there is any conflict between the English text and the translation, English controls.

Clicking on the translation link activates a free translation service to convert the page to Spanish. As with any Internet translation, the conversion is not context-sensitive and may not translate the text to its original meaning. NC State Extension does not guarantee the accuracy of the translated text. Please note that some applications and/or services may not function as expected when translated.

Collapse ▲

Source – Capital Press

By John O’Connell

Date – 13 Jan 2016

Website – www.capitalpress.com

J.R. Simplot Co.’s second-generation Innate potato has been approved by the federal Food and Drug Administration.

BOISE — The J.R. Simplot Co. announced Jan. 13 it has obtained federal Food and Drug Administration approval for the second generation of its Innate line of potatoes, developed with biotechnology.
The company plans to raise less than 100 acres of second-generation Innate Russet Burbanks this season in anticipation of approval by the U.S. Environmental Protection Agency, which is expected by December and would represent the final step in the review process.

Innate’s second generation was previously approved by USDA, and the company voluntarily sought FDA approval, said Simplot spokesman Doug Cole.

“(FDA approval) is something most all biotech companies will go through because it gives customers an assurance of safety,” Cole said. “We will pursue it for all of our various (Innate) generations.”

Innate lines utilize genes introduced through biotechnology from wild and cultivated potatoes, which has led to concerns by some in the industry that the product could affect foreign trade markets where consumers are wary of genetically modified organisms. The first generation of Innate, which offered low bruising, non-browning and low acrylamide, was approved by FDA last March and saw its first significant commercial production in 2015. The second generation includes the original traits, plus improved cold storage and late blight resistance.

Because of the late blight resistance trait, the second generation of Innate must also undergo review by EPA, which is tasked with assessing pesticides, despite the fact that the protection is incorporated into the plant.

Read more.

More information on second generation Innate potato.

Company press release.